Pathogenetic Mechanisms of the Acquired Immune Deficiency Syndrome
Reference146 articles.
1. Allain, J-P., Laurian, Y., Paul, D. A., and Senn, D., 1986, Serological markers in early stages of HIV infection in hemophilia, Lancet 2: 1233–1236. 2. Allain, J-P., Laurian, Y., Paul, D. P., Verroust, F., Leather, M., Gazengel, C., Senn, D., Larrieu, M- J., and Bosser, C., 1987, Long-term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia: Potential clinical importance, N. Engl. J. Med. 317: 1114–1121. 3. Allan, J. S., Coligan, J. E., Barin, F., McLane, M. F., Sodroski, J. G., Rosen, C., Haseltine, W. A., Lee, T. H., and Essex, M., 1985, Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HIV, Science 228: 1091–1094. 4. Ammann, A. J., Abrams, D., Conant, M., Dhudwin, D., Cowan, M., Volberding, P., Lewis, B., and Casavant, C., 1983. Acquired immune dysfunction in homosexual men: Immunologic profiles, Clin. Immunol. Immunopathol. 27: 315–325. 5. Ammann, A. J., Schiffman, G., Abrams, D., Voldberding, P., Ziegler, J., and Conant, M., 1984, B- cell immunodeficiency in acquired immune deficiency syndrome, JAMA 251: 1447–1449.
|
|